An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils

  1. Emil Dandanell Agerschou
  2. Patrick Flagmeier
  3. Theodora Saridaki
  4. Céline Galvagnion
  5. Daniel Komnig
  6. Laetitia Heid
  7. Vibha Prasad
  8. Hamed Shaykhalishahi
  9. Dieter Willbold
  10. Christopher M Dobson
  11. Aaron Voigt
  12. Björn Falkenbürger  Is a corresponding author
  13. Wolfgang Hoyer  Is a corresponding author
  14. Alexander K Buell  Is a corresponding author
  1. Heinrich Heine University Düsseldorf, Germany
  2. University of Cambridge, United Kingdom
  3. RWTH Aachen University, Germany
  4. Technical University of Denmark, Denmark

Abstract

Removing or preventing the formation of α-synuclein aggregates is a plausible strategy against Parkinson's disease. To this end we have engineered the β-wrapin AS69 to bind monomeric α-synuclein with high affinity. In cultured cells, AS69 reduced the self-interaction of α-synuclein and the formation of visible α-synuclein aggregates. In flies, AS69 reduced α-synuclein aggregates and the locomotor deficit resulting from α-synuclein expression in neuronal cells. In biophysical experiments in vitro, AS69 highly sub-stoichiometrically inhibited both primary and autocatalytic secondary nucleation processes, even in the presence of a large excess of monomer. We present evidence that the AS69-α-synuclein complex, rather than the free AS69, is the inhibitory species responsible for sub-stoichiometric inhibition of secondary nucleation. These results represent a new paradigm that high affinity monomer binders can lead to strongly sub-stoichiometric inhibition of nucleation processes.

Data availability

- Numerical data represented in the graphs for cell culture and fly experiments will be made publicly available on osf.io as we did for previous publications.- The numerical data for the biophysical experiments will be made publicly available within the same repository on osf.io.- The raw images of the gels used in the publication will be made publicly available.All data have been deposited on osf.io ( https://osf.io/6n2gs/?view_only=7eb7024d8ecb460a817cd0ed35978339 ) and will be made available in the event of publication

The following data sets were generated

Article and author information

Author details

  1. Emil Dandanell Agerschou

    Institute of Physical Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Patrick Flagmeier

    Department of Chemistry, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1204-5340
  3. Theodora Saridaki

    Department of Neurology, RWTH Aachen University, Aachen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Céline Galvagnion

    Institute of Physical Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Daniel Komnig

    Department of Neurology, RWTH Aachen University, Aachen, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6312-5236
  6. Laetitia Heid

    Institute of Physical Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Vibha Prasad

    Department of Neurology, RWTH Aachen University, Aachen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Hamed Shaykhalishahi

    Institute of Physical Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Dieter Willbold

    Institute of Physical Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0065-7366
  10. Christopher M Dobson

    Department of Chemistry, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Aaron Voigt

    Department of Neurology, RWTH Aachen University, Aachen, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0428-7462
  12. Björn Falkenbürger

    Department of Neurology, RWTH Aachen University, Aachen, Germany
    For correspondence
    bfalkenburger@ukaachen.de
    Competing interests
    The authors declare that no competing interests exist.
  13. Wolfgang Hoyer

    Institute of Physical Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
    For correspondence
    wolfgang.hoyer@hhu.de
    Competing interests
    The authors declare that no competing interests exist.
  14. Alexander K Buell

    Biotechnology and Biomedicine, Technical University of Denmark, Kgs Lyngby, Denmark
    For correspondence
    alebu@dtu.dk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1161-3622

Funding

Leverhulme Trust

  • Alexander K Buell

Boehringer Ingelheim Fonds

  • Patrick Flagmeier

Studienstiftung des Deutschen Volkes

  • Patrick Flagmeier

Alexander von Humboldt-Stiftung

  • Céline Galvagnion

H2020 European Research Council (726368)

  • Céline Galvagnion

Parkinson's and Movement Disorder Foundation

  • Alexander K Buell

European Commission (706551)

  • Céline Galvagnion

Novo Nordisk Foundation

  • Alexander K Buell

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Andrew B West, Duke University, United States

Publication history

  1. Received: February 25, 2019
  2. Accepted: August 4, 2019
  3. Accepted Manuscript published: August 7, 2019 (version 1)
  4. Accepted Manuscript updated: August 21, 2019 (version 2)
  5. Version of Record published: September 3, 2019 (version 3)
  6. Version of Record updated: December 11, 2019 (version 4)

Copyright

© 2019, Agerschou et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,697
    Page views
  • 754
    Downloads
  • 36
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Emil Dandanell Agerschou
  2. Patrick Flagmeier
  3. Theodora Saridaki
  4. Céline Galvagnion
  5. Daniel Komnig
  6. Laetitia Heid
  7. Vibha Prasad
  8. Hamed Shaykhalishahi
  9. Dieter Willbold
  10. Christopher M Dobson
  11. Aaron Voigt
  12. Björn Falkenbürger
  13. Wolfgang Hoyer
  14. Alexander K Buell
(2019)
An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils
eLife 8:e46112.
https://doi.org/10.7554/eLife.46112
  1. Further reading

Further reading

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Jinli Geng, Yingjun Tang ... Xiaodong Liu
    Research Article Updated

    Dynamic Ca2+ signals reflect acute changes in membrane excitability, and also mediate signaling cascades in chronic processes. In both cases, chronic Ca2+ imaging is often desired, but challenged by the cytotoxicity intrinsic to calmodulin (CaM)-based GCaMP, a series of genetically-encoded Ca2+ indicators that have been widely applied. Here, we demonstrate the performance of GCaMP-X in chronic Ca2+ imaging of cortical neurons, where GCaMP-X by design is to eliminate the unwanted interactions between the conventional GCaMP and endogenous (apo)CaM-binding proteins. By expressing in adult mice at high levels over an extended time frame, GCaMP-X showed less damage and improved performance in two-photon imaging of sensory (whisker-deflection) responses or spontaneous Ca2+ fluctuations, in comparison with GCaMP. Chronic Ca2+ imaging of one month or longer was conducted for cultured cortical neurons expressing GCaMP-X, unveiling that spontaneous/local Ca2+ transients progressively developed into autonomous/global Ca2+ oscillations. Along with the morphological indices of neurite length and soma size, the major metrics of oscillatory Ca2+, including rate, amplitude and synchrony were also examined. Dysregulations of both neuritogenesis and Ca2+ oscillations became discernible around 2–3 weeks after virus injection or drug induction to express GCaMP in newborn or mature neurons, which were exacerbated by stronger or prolonged expression of GCaMP. In contrast, neurons expressing GCaMP-X were significantly less damaged or perturbed, altogether highlighting the unique importance of oscillatory Ca2+ to neural development and neuronal health. In summary, GCaMP-X provides a viable solution for Ca2+ imaging applications involving long-time and/or high-level expression of Ca2+ probes.

    1. Neuroscience
    Maria Cecilia Martinez, Camila Lidia Zold ... Mariano Andrés Belluscio
    Research Article

    The automatic initiation of actions can be highly functional. But occasionally these actions cannot be withheld and are released at inappropriate times, impulsively. Striatal activity has been shown to participate in the timing of action sequence initiation and it has been linked to impulsivity. Using a self-initiated task, we trained adult male rats to withhold a rewarded action sequence until a waiting time interval has elapsed. By analyzing neuronal activity we show that the striatal response preceding the initiation of the learned sequence is strongly modulated by the time subjects wait before eliciting the sequence. Interestingly, the modulation is steeper in adolescent rats, which show a strong prevalence of impulsive responses compared to adults. We hypothesize this anticipatory striatal activity reflects the animals’ subjective reward expectation, based on the elapsed waiting time, while the steeper waiting modulation in adolescence reflects age-related differences in temporal discounting, internal urgency states, or explore–exploit balance.